Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

DHL invests $400M in its pharma and medtech supply chain

By Sean Whooley | February 2, 2022

DHL Supply ChainDHL Supply Chain announced today that it will invest upwards of $400 million to expand its pharmaceutical and medical device distribution network footprint.

Westerville, Ohio-based DHL Supply Chain’s life sciences and healthcare (LSHC) sector will make the investment to expand the supply chain footprint by 27% this year, amounting to nearly 3 million additional square feet.

The company said in a news release that the ultimate goal of the expansion is to bring critical healthcare products closer to trade partners and patients. DHL Supply Chain’s investment includes six new U.S. sites by the end of 2022, with costs to invest in new buildings and technology as well as the fit-out and start-up of new or expanded operations.

With the expansion, DHL Supply Chain’s LSHC sites will grow to 34 in total by the end of 2022, including strategic locations in Georgia, Cincinnati, Tennessee, Nevada and Pennsylvania. The new builds as part of the investment will be fully licensed with temperature-controlled space that supports pharmaceutical storage requirements and they will allow integrated solutions for both packaging and managed transportation.

“This latest investment in our Life Sciences and Healthcare sector is testament to our track record and pedigree for delivering unrivaled supply chain expertise to our partners,” DHL Supply Chain North America President of LSHC Jim Saponaro said in the release. “This substantial expansion will only further deepen the connections between our customers and the patients they serve by providing best-in-class end-to-end supply chain solutions.”

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
Thermo Fisher Scientific
Thermo Fisher to invest $2B on U.S. manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE